Purdue Researchers Create Biocompatible Nanoparticles to Enhance Systemic Delivery of Cancer Immunotherapy
March 28, 2024
March 28, 2024
WEST LAFAYETTE, Indiana, March 28 (TNSres) -- Purdue University issued the following news release:
* * *
PLGA nanoparticles modified with ATP slowly release anti-cancer drugs and recruit immune cells to fight tumors
* * *
Purdue University researchers are developing and validating patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to enhance immunotherapy effects against malignant . . .
* * *
PLGA nanoparticles modified with ATP slowly release anti-cancer drugs and recruit immune cells to fight tumors
* * *
Purdue University researchers are developing and validating patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to enhance immunotherapy effects against malignant . . .